Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Yearbook of Dermatology and Dermatologic Surgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0093-3619(10)79624-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

  2009cited by this paper

• Lack of molecular mimicry between HPV vaccine L1 antigen and human proteins by a computational analysis

  2026cites this paper
• Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials

  2025cites this paper
• TCR CDR3 chemical complementarity to HPV epitopes is associated with a better outcome for cervical cancer

  2025cites this paper
• Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial

  2024cites this paper
• Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis

  2024cites this paper
• Recovery from HPV vaccination deficits caused by the COVID-19 pandemic in Germany: a modeling study of catch-up HPV vaccination among adolescent girls

  2024cites this paper
• Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery

  2023cites this paper
• Updates on HPV Vaccination

  2023cites this paper
• Raman Spectroscopy for Early Detection of Cervical Cancer, a Global Women’s Health Issue—A Review

  2023cites this paper
• Efficacy of HPV vaccine in preventing cervical cancer in the Tomsk region

  2023cites this paper
• Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe

  2023cites this paper
• Human Papillomavirus Vaccines

  2023cites this paper
• Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

  2023cites this paper
• HPV and the Risk of HIV Acquisition in Women

  2022cites this paper
• Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women

  2022cites this paper
• Prevention and Treatment of Oral Squamous Cell Carcinoma-A Mini Review

  2022cites this paper
• The cost-effectiveness of human papillomavirus vaccination in the Philippines.

  2022cites this paper
• Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa

  2022cites this paper
• Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in Norway

  2022cites this paper
• A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities

  2021cites this paper
• Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge

  2021cites this paper
• Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis

  2021cites this paper
• Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns.

  2021cites this paper
• Anti-cancer activity of human gastrointestinal bacteria

  2021cites this paper
• An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

  2021cites this paper
• Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study

  2021cites this paper
• Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers

  2021cites this paper
• Optimal treatment in locally advanced cervical cancer

  2021cites this paper
• Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program

  2021cites this paper
• Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014–2019

  2020cites this paper
• Evaluation of an Inpatient Postpartum Human Papillomavirus Immunization Program.

  2020cites this paper
• Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case‐control study

  2020cites this paper
• Mode of delivery does not have a relationship with high-risk HPV positivity

  2020cites this paper
• Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study

  2020cites this paper
• Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison

  2020cites this paper
• Vaginal Intraepithelial Neoplasia: Diagnostics, Treatment, and Prevention

  2020cites this paper
• Changing attitudes in Japan toward HPV vaccination: a 5-year follow-up survey of obstetricians and gynecologists regarding their current opinions about the HPV vaccine

  2020cites this paper
• Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis.

  2020cites this paper
• Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications

  2020cites this paper
• Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression

  2020cites this paper
• Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial

  2020cites this paper
• Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

  2020cites this paper
• Cost-effectiveness of 2-dose human papillomavirus vaccination for 12-year-old girls in Zhejiang Province: implications for China’s expanded program on immunization

  2020cites this paper
• A Systematic Review: Adolescent Cannabis Use and Suicide

  2020cites this paper
• MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA: IMPACT ON PRETERM BIRTH, POSTTREATMENT FOLLOW-UP AND HEALTH-RELATED QUALITY OF LIFE

  2020cites this paper
• Meta‐analysis of the risk of autoimmune thyroiditis, Guillain‐Barré syndrome, and inflammatory bowel disease following vaccination with AS04‐adjuvanted human papillomavirus 16/18 vaccine

  2020cites this paper
• HPV Vaccination and the Risk of Invasive Cervical Cancer.

  2020cites this paper
• A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

  2019cites this paper
• Turning the corner on therapeutic cancer vaccines

  2019cites this paper
• Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats.

  2019cites this paper
• Human Papillomavirus awareness and vaccine acceptability among men who have sex with men from mainland China

  2019cites this paper
• A mobile-phone based high-resolution microendoscope to image cervical precancer

  2019cites this paper
• Parasite-microbe-host interactions and cancer risk

  2019cites this paper
• Cost-effectiveness analysis of HPV vaccination of boys in Belgium

  2019cites this paper
• The effectiveness of vaccination to prevent the papillomavirus infection: a systematic review and meta-analysis

  2019cites this paper
• Molecular characterization of HPV infection: Evaluation of vaccine effects, viral diversity and variant development

  2019cites this paper
• Should female sex workers be offered HPV vaccination?

  2019cites this paper
• Significance and Role of Pattern Recognition Receptors in Malignancy

  2019cites this paper
• Nanomedicine for cancer targeted drug delivery, early detection mechanism and therapeutics

  2019cites this paper
• Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Cancer prevention and screening: the next step in the era of precision medicine

  2019cites this paper
• Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction

  2019cites this paper
• Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients?

  2019cites this paper
• Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial

  2019cites this paper
• Prevention is better than cure

  2019cites this paper
• Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.

  2019cites this paper
• Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets

  2019cites this paper
• Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?

  2019cites this paper
• Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program

  2019cites this paper
• An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway

  2019cites this paper
• Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection

  2019cites this paper
• Contemporary Issues in Women's Health

  2019cites this paper
• Cervical Cancer Prevention and Treatment: A Succinct Review

  2018cites this paper
• The Health Benefits, Resource Use and Cost-Effectiveness of Current and Future Cervical Cancer Screening Policies in Norway

  2018cites this paper
• Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

  2018cites this paper
• KNOWLEDGE AND ATTITUDE OF CERVICAL CANCER SCREENING AMONG WOMEN IN HAIL

  2018cites this paper
• Reducing incidence of cervical cancer: knowledge and attitudes of caregivers in Nigerian city to human papilloma virus vaccination

  2018cites this paper
• Opinion: Making Inactivated and Subunit-Based Vaccines Work

  2018cites this paper
• Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China

  2018cites this paper
• Detection and Genotyping of HPV DNA in a Group of Unvaccinated Young Women from Colombia: Baseline Measures Prior to Future Monitoring Program

  2018cites this paper
• Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine

  2018cites this paper
• Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention.

  2018cites this paper
• Portable Pocket colposcopy performs comparably to standard‐of‐care clinical colposcopy using acetic acid and Lugol's iodine as contrast mediators: an investigational study in Peru

  2018cites this paper
• Safety of Human Papillomavirus Vaccines: An Updated Review

  2018cites this paper
• Perspectives on cervical cancer screening and prevention: challenges faced by providers and patients along the Texas–Mexico border

  2018cites this paper
• Identification of functional single nucleotide polymorphisms (SNPs) in High Risk-Human Papillomavirus (HR-HPV) related diseases

  2018cites this paper
• High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women

  2018cites this paper
• Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy

  2018cites this paper
• Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore.

  2018influential citation
• Incidence Trends of Cervical Cancer and Its Precancerous Lesions in Women of Central Switzerland from 2000 until 2014

  2018cites this paper
• Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1

  2018cites this paper
• Assessment Of An Educational Intervention To Increase Knowledge And Intention To Take HPV Vaccine And Cervical Cancer Screening In Nigeria

  2018cites this paper
• Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia

  2018influential citation
• Human Papillomavirus Prophylactic Vaccination improves reproductive outcome in infertile patients with HPV semen infection: a retrospective study

  2018cites this paper
• Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients

  2017cites this paper
• Manejo conservador de lesiones de alto grado cervicales en mujeres jóvenes. Estudio longitudinal prospectivo

  2017cites this paper
• Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice

  2017cites this paper
• Distribution of Human Papillomavirus Genotype in Anal Condyloma Acuminatum Among Japanese Men: The Higher Prevalence of High Risk Human Papillomavirus in Men Who Have Sex with Men with HIV Infection

  2017influential citation
• Impfung gegen humane Papillomviren. Wirksamkeit und Nebenwirkungen

  2017cites this paper
• Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial

  2017cites this paper